Benralizumab

BR

  • Product Code: 110334
  CAS:    1044511-01-4
Molecular Weight: 146054 g./mol Molecular Formula: C₆₄₉₂H₁₀₀₆₀N₁₇₂₄O₂₀₂₈S₄₂
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: -20°C, airtight, dry
Product Description: Benralizumab is primarily used in the treatment of severe eosinophilic asthma. It works by targeting and reducing the number of eosinophils, a type of white blood cell that contributes to inflammation in the airways. This medication is particularly effective for patients who have not responded well to standard asthma treatments. By decreasing eosinophil levels, it helps to control asthma symptoms, reduce the frequency of exacerbations, and improve overall lung function. It is administered via subcutaneous injection, typically once every four to eight weeks, making it a convenient option for long-term management of severe asthma.
Product Specification:
Test Specification
Appearance Colorless To Light Yellow Liquid
Purity (%) 98
Concentration 30 mg/ml
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.100 10-20 days ฿227,740.00
+
-
Benralizumab
Benralizumab is primarily used in the treatment of severe eosinophilic asthma. It works by targeting and reducing the number of eosinophils, a type of white blood cell that contributes to inflammation in the airways. This medication is particularly effective for patients who have not responded well to standard asthma treatments. By decreasing eosinophil levels, it helps to control asthma symptoms, reduce the frequency of exacerbations, and improve overall lung function. It is administered via subcutaneous injection, typically once every four to eight weeks, making it a convenient option for long-term management of severe asthma.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: ฿0.00
฿0.00 Total :